about
Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studiesPrevalence, determinants, and inappropriateness of calcium supplementation among men and women in a Spanish Mediterranean area: cross-sectional data from the ESOSVAL cohort.Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study.Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study.Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD studyTiming of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System.Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysisImpact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study).When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.Use of osteoporosis medications after hospitalization for hip fracture: a cross-national studyOveruse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341 632 participants.Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: qualitative synthesis of scientific evidence.Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence.Did HEDIS get it right? Evaluating the quality of a quality measure: adherence to β-blockers and cardiovascular outcomes after myocardial infarction.Antibiotic Use in Children - A Cross-National Analysis of 6 Countries.Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European RegionPrimary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.[Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)].Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.[Variability in the recommendations for the clinical management of osteoporosis].Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study.Carpal tunnel release surgery: small-area variation and impact of ambulatory surgery in the autonomous region of Valencia, Spain.Trends in gastrointestinal bleeding in the Region of Valencia (2000-2005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medication.Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain.[Effectiveness of drugs used in degenerative joint diseases (arthroses)].Trends of uncontrolled blood pressure in Spain: an updated meta-regression analysis.[Review of the evidence about drugs used as SYSADOA].Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.Primary Non-Adherence to Antiosteoporotic Treatment and Associated Factors: A Prospective Cohort Study in Spain.Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation.Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain.[Opportunities for improvement in the management of osteoporosis. Time to tackle the essential].Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.
P50
Q21260319-F111573B-625C-4582-A28A-DA7CD3DFCB2DQ30623972-D32D20B1-023B-4919-ADED-EC1FDDC8067EQ31161075-9A89D64F-3216-46DF-9E44-BD30922256F7Q31170904-9ADC88E8-E1A5-4872-A9A5-D30DDDFA30E1Q33545420-51536CED-2484-4F31-9B96-655CDFA0C540Q33724697-A56E0F97-C217-4131-9818-28050F6BDCF2Q33980726-31244E4B-7E0E-4728-9751-EB3C7DBC8BA3Q34132586-655BEA79-C432-402E-BDE2-DDF2873EAA5FQ34292774-0CD681DB-3208-4AAC-8857-C5AA568855CFQ34825342-96A03862-03CB-4B17-BEF9-CCDBCD569EE3Q34828582-049FAECF-01F5-4D45-9E1D-64B343AAF0ADQ35554696-43150930-37BB-4D20-978A-8780E2282C37Q35759160-A1DE0DAD-19B7-4F42-AF52-26ECCDABB626Q36110118-34999B97-4827-484D-91C2-33736310F595Q36179688-806D972D-8A7A-4F7B-AD69-CBD68BBA9670Q37949282-8546FC38-AA9B-48A0-AB26-EED750DBB5E7Q38085871-58B6598F-979C-4665-AE16-128EC7DF2BC1Q38107765-014FA8BA-C0DA-4121-82D5-EE2BE50E45CCQ38219997-C885AC59-5AE7-4867-AA7A-133526BD45CDQ39066713-5C95606D-766F-414B-B068-7B3DE94FA725Q41481474-050656E9-6825-4718-A0DE-C0A3A83F9023Q41538362-C6DA74AA-C609-478F-92E8-6C7C0720344CQ41717921-7A0CF371-9C96-4EAF-93CD-E80DB335BBC8Q42878268-72CA79CE-DA8D-4148-AE4A-49FA9588AEC8Q43265650-792E8792-F103-435D-BCE0-5BA62BC2FA99Q43524861-3FA6CA83-50B9-4880-BA86-DA9D5018491DQ44280838-DD12A376-CE11-4DD8-8F8E-41CF5FB263A2Q44577384-E0C9DD33-5195-4522-B591-625A8BF6ED91Q44823140-B7735DE0-8D5D-43AB-8370-D5CF41F58083Q45713330-4B22AE53-2548-47D5-8253-FC1B7603261AQ45733330-0877B458-4AB7-48F9-AC26-47EA6693B95BQ46649947-685E0678-95D7-4F35-AEF9-E8677CDE4320Q46883095-B4E97076-27E4-4664-9B80-924E4A9FFA84Q46900572-F42C8A12-C182-435D-89F7-F5E3DFD5F84EQ47727017-4C7E95EF-4114-4D2A-A86B-7820D0AA67C0Q50278993-D817D7C3-0105-4BCE-AE78-DBFBA7A096ADQ50279005-C0B44A25-554E-456E-86D1-08A36BC5D77EQ50481515-F96B5839-6B6B-4155-90D8-53A29EFCECC4Q50483678-D6237236-039B-4A9F-B516-6109D03EE9C9Q52563793-7B8DB4BE-3087-48E3-AFB9-A6896191D986
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gabriel Sanfélix-Gimeno
@ast
Gabriel Sanfélix-Gimeno
@en
Gabriel Sanfélix-Gimeno
@es
Gabriel Sanfélix-Gimeno
@nl
Gabriel Sanfélix-Gimeno
@sl
type
label
Gabriel Sanfélix-Gimeno
@ast
Gabriel Sanfélix-Gimeno
@en
Gabriel Sanfélix-Gimeno
@es
Gabriel Sanfélix-Gimeno
@nl
Gabriel Sanfélix-Gimeno
@sl
prefLabel
Gabriel Sanfélix-Gimeno
@ast
Gabriel Sanfélix-Gimeno
@en
Gabriel Sanfélix-Gimeno
@es
Gabriel Sanfélix-Gimeno
@nl
Gabriel Sanfélix-Gimeno
@sl
P1053
E-9140-2012
P106
P21
P31
P3829
P496
0000-0001-7098-4576